Pharmato is a Chinese medical-AI startup founded in 2025 and based in Suzhou, built by two veterans of the pharmaceutical big-data industry. Its Integras platform pairs a multimodal pharma knowledge base with high-reliability AI agents for evidence-based analysis and a global drug-pipeline merging tool, sold to pharma companies through a products-plus-consulting-plus-data model that has served more than 20 consulting clients and close to 600 enterprise users. The company is now extending this stack into virtual clinical trials, aiming to help sponsors and CROs spot protocol, enrollment and cost risks before a trial starts and optimize it while it runs.
1
Round
1
Industry
5
Tags
Oct 12, 2026
Latest raise
Funding activity · 1 round
Oct 12, 2026
Seed
Led by Enbo Life (恩铂生命)
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
